PUBLISHER: Polaris Market Research | PRODUCT CODE: 1238748
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1238748
Angiogenesis Inhibitors and Stimulators Market Share, Size, Trends, Industry Analysis Report, By Product (Sprouting Angiogenesis, Intussusceptive Angiogenesis); By Application; By Region; Segment Forecast, 2023-2032
The global angiogenesis inhibitors and stimulators market size is expected to reach USD 67.17 billion by 2032, according to a new study by Polaris Market Research. The report "Angiogenesis Inhibitors and stimulators Market Share, Size, Trends, Industry Analysis Report, By Product (Sprouting Angiogenesis, Intussusceptive Angiogenesis); By Application; By Region; Segment Forecast, 2023-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The surge in cancer cases, robust pipeline of drugs, industry-academia collaboration, increased awareness of the therapeutic options provided by cancer drugs & increased investment in research & development will drive the market. Furthermore, technical innovation increased awareness, and the usage of angiogenesis inhibitors in treating several indications will significantly fuel market growth throughout the projection period. However, rigorous government regulations & expensive treatment costs could stymie market expansion throughout the projection period.
Increased awareness of angiogenesis inhibitors' potential advantages, such as axitinib and cabozantinib, is expected to increase healthcare professionals' trust, boost angiogenesis inhibitors, and stimulate market growth. Moreover, research and development efforts that result in innovative therapeutics are growth variables that support market expansion. Furthermore, the availability of therapeutic alternatives and a healthy pipeline leading to prospective medications will fuel the expansion of the angiogenesis inhibitors market. Furthermore, according to the National Cancer Institute, there were roughly 1,660,290 cases recorded in the United States in 2018.
The most significant level of research and development activity is for creating innovative angiogenesis medicines for cancer therapy. As a result, the rising number of cancer cases will fuel market expansion throughout the projection period.
Bevacizumab was the first anti-angiogenic inhibitor, a recombinant humanized monoclonal antibody (mAb) that blocks VEGF-A. Bevacizumab intravenously depletes VEGF in the circulation and perfused tissues, blocking the interaction between VEGF and VEGFRs. Nilotinib works by inhibiting the activation of VEGFR2, PDGFR, and FGFR1, as well as their shared downstream ERK signaling. As a result, anlotinib has the potential to reduce angiogenesis and be used in tumor treatment.
Angiogenesis Inhibitors and Stimulators Market Report Highlights
Sprouting Angiogenesis is anticipated to grow at a significant CAGR over the forecast period due to rising demand of the inhibitors in the market.
Hospitals sector is expected to grow at a faster rate due to its capability to provide advanced angiogenesis treatments and therapy.
North America dominates the market in terms of market share and revenue due to rising cancer incidences in the country.
The global players include Abbott, Amgen Inc, AstraZeneca, Bristol-Myers Squibb Company, Casi Pharmaceuticals Inc, Eyetech digital systems, F. hoffman-la roche Itd, Johns Hopkins medicines, Novartis AG, and Pfizer.
Polaris Market Research has segmented the angiogenesis inhibitors and stimulators market report based on product, application, and region:
Angiogenesis Inhibitors and Stimulators, Product Outlook (Revenue - USD Billion, 2019 - 2032)
Sprouting Angiogenesis
Intussusceptive Angiogenesis
Angiogenesis Inhibitors and Stimulators, Application Outlook (Revenue - USD Billion, 2019 - 2032)
Hospitals
Clinics
Others
Angiogenesis Inhibitors and Stimulators, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Angiogenesis Inhibitors and Stimulators Market Insights
- 4.1. Angiogenesis Inhibitors and Stimulators Market - Industry Snapshot
- 4.2. Angiogenesis Inhibitors and Stimulators Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Government initiatives to increase cancer awareness
- 4.2.1.2. Rising worldwide burden of cancers
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High cost of the inhibitor
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. Angiogenesis Inhibitors and Stimulators Industry trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Angiogenesis Inhibitors and Stimulators Market, by Product
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Angiogenesis Inhibitors and Stimulators, by Product, 2019-2032 (USD Billion)
- 5.3. Sprouting Angiogenesis
- 5.3.1. Global Angiogenesis Inhibitors and Stimulators Market, by Sprouting Angiogenesis, by Region, 2019-2032 (USD Billion)
- 5.4. Intussusceptive Angiogenesis
- 5.4.1. Global Angiogenesis Inhibitors and Stimulators Market, by Intussusceptive Angiogenesis, by Region, 2019-2032 (USD Billion)
6. Global Angiogenesis Inhibitors and Stimulators Market, by Application
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- 6.3. Hospitals
- 6.3.1. Global Angiogenesis Inhibitors and Stimulators Market, by Hospitals, by Region, 2019-2032 (USD Billion)
- 6.4. Clinics
- 6.4.1. Global Angiogenesis Inhibitors and Stimulators Market, by Clinics, by Region, 2019-2032 (USD Billion)
- 6.5. Others
- 6.5.1. Global Angiogenesis Inhibitors and Stimulators Market, by Others, by Region, 2019-2032 (USD Billion)
7. Global Angiogenesis Inhibitors and Stimulators Market, by Geography
- 7.1. Key findings
- 7.2. Introduction
- 7.2.1. Angiogenesis Inhibitors and Stimulators Market Assessment, By Geography, 2019-2032 (USD Billion)
- 7.3. Angiogenesis Inhibitors and Stimulators Market - North America
- 7.3.1. North America: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- 7.3.2. North America: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- 7.3.3. Angiogenesis Inhibitors and Stimulators Market - U.S.
- 7.3.3.1. U.S.: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- 7.3.3.2. U.S.: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- 7.3.4. Angiogenesis Inhibitors and Stimulators Market - Canada
- 7.3.4.1. Canada: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- 7.3.4.2. Canada: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- 7.4. Angiogenesis Inhibitors and Stimulators Market - Europe
- 7.4.1. Europe: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- 7.4.2. Europe: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- 7.4.3. Angiogenesis Inhibitors and Stimulators Market - UK
- 7.4.3.1. UK: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- 7.4.3.2. UK: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- 7.4.4. Angiogenesis Inhibitors and Stimulators Market - France
- 7.4.4.1. France: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- 7.4.4.2. France: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- 7.4.5. Angiogenesis Inhibitors and Stimulators Market - Germany
- 7.4.5.1. Germany: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- 7.4.5.2. Germany: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- 7.4.6. Angiogenesis Inhibitors and Stimulators Market - Italy
- 7.4.6.1. Italy: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- 7.4.6.2. Italy: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- 7.4.7. Angiogenesis Inhibitors and Stimulators Market - Spain
- 7.4.7.1. Spain: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- 7.4.7.2. Spain: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- 7.4.8. Angiogenesis Inhibitors and Stimulators Market - Netherlands
- 7.4.8.1. Netherlands: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- 7.4.8.2. Netherlands: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- 7.4.9. Angiogenesis Inhibitors and Stimulators Market - Russia
- 7.4.9.1. Russia: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- 7.4.9.2. Russia: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- 7.5. Angiogenesis Inhibitors and Stimulators Market - Asia Pacific
- 7.5.1. Asia Pacific: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- 7.5.2. Asia Pacific: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- 7.5.3. Angiogenesis Inhibitors and Stimulators Market - China
- 7.5.3.1. China: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- 7.5.3.2. China: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- 7.5.4. Angiogenesis Inhibitors and Stimulators Market - India
- 7.5.4.1. India: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- 7.5.4.2. India: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- 7.5.5. Angiogenesis Inhibitors and Stimulators Market - Malaysia
- 7.5.5.1. Malaysia: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- 7.5.5.2. Malaysia: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- 7.5.6. Angiogenesis Inhibitors and Stimulators Market - Japan
- 7.5.6.1. Japan: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- 7.5.6.2. Japan: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- 7.5.7. Angiogenesis Inhibitors and Stimulators Market - Indonesia
- 7.5.7.1. Indonesia: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- 7.5.7.2. Indonesia: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- 7.5.8. Angiogenesis Inhibitors and Stimulators Market - South Korea
- 7.5.8.1. South Korea: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- 7.5.8.2. South Korea: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- 7.6. Angiogenesis Inhibitors and Stimulators Market - Middle East & Africa
- 7.6.1. Middle East & Africa: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- 7.6.2. Middle East & Africa: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- 7.6.3. Angiogenesis Inhibitors and Stimulators Market - Saudi Arabia
- 7.6.3.1. Saudi Arabia: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- 7.6.3.2. Saudi Arabia: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- 7.6.4. Angiogenesis Inhibitors and Stimulators Market - UAE
- 7.6.4.1. UAE: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- 7.6.4.2. UAE: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- 7.6.5. Angiogenesis Inhibitors and Stimulators Market - Israel
- 7.6.5.1. Israel: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- 7.6.5.2. Israel: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- 7.6.6. Angiogenesis Inhibitors and Stimulators Market - South Africa
- 7.6.6.1. South Africa: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- 7.6.6.2. South Africa: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- 7.7. Angiogenesis Inhibitors and Stimulators Market - Latin America
- 7.7.1. Latin America: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- 7.7.2. Latin America: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- 7.7.3. Angiogenesis Inhibitors and Stimulators Market - Mexico
- 7.7.3.1. Mexico: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- 7.7.3.2. Mexico: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- 7.7.4. Angiogenesis Inhibitors and Stimulators Market - Brazil
- 7.7.4.1. Brazil: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- 7.7.4.2. Brazil: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- 7.7.5. Angiogenesis Inhibitors and Stimulators Market - Argentina
- 7.7.5.1. Argentina: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- 7.7.5.2. Argentina: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
8. Competitive Landscape
- 8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
- 8.2. Partnerships/Collaborations/Agreements/Exhibitions
9. Company Profiles
- 9.1. Abbott
- 9.1.1. Company Overview
- 9.1.2. Financial PerApplicationance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
- 9.2. Amgen Inc
- 9.2.1. Company Overview
- 9.2.2. Financial PerApplicationance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
- 9.3. AstraZeneca
- 9.3.1. Company Overview
- 9.3.2. Financial PerApplicationance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
- 9.4. Bristol-Myers Squibb Company
- 9.4.1. Company Overview
- 9.4.2. Financial PerApplicationance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
- 9.5. Casi Pharmaceuticals
- 9.5.1. Company Overview
- 9.5.2. Financial PerApplicationance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
- 9.6. Eyetech digital systems
- 9.6.1. Company Overview
- 9.6.2. Financial PerApplicationance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
- 9.7. Roche
- 9.7.1. Company Overview
- 9.7.2. Financial PerApplicationance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
- 9.8. Johns Hopkins Medicine
- 9.8.1. Company Overview
- 9.8.2. Financial PerApplicationance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
- 9.9. Novartis
- 9.9.1. Company Overview
- 9.9.2. Financial PerApplicationance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
- 9.10. Pfizer
- 9.10.1. Company Overview
- 9.10.2. Financial PerApplicationance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
List of Tables
- Table 1 Global Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- Table 2 Global Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- Table 3 Angiogenesis Inhibitors and Stimulators Market Assessment, By Geography, 2019-2032 (USD Billion)
- Table 4 North America: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- Table 5 North America: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- Table 6 U.S.: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- Table 7 U.S.: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- Table 8 Canada: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- Table 9 Canada: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- Table 10 Europe: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- Table 11 Europe: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- Table 12 UK: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- Table 13 UK: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- Table 14 France: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- Table 15 France: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- Table 16 Germany: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- Table 17 Germany: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- Table 18 Italy: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- Table 19 Italy: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- Table 20 Spain: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- Table 21 Spain: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- Table 22 Netherlands: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- Table 23 Netherlands: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- Table 24 Russia: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- Table 25 Russia: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- Table 26 Asia Pacific: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- Table 27 Asia Pacific: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- Table 28 China: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- Table 29 China: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- Table 30 India: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- Table 31 India: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- Table 32 Malaysia: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- Table 33 Malaysia: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- Table 34 Japan: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- Table 35 Japan: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- Table 36 Indonesia: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- Table 37 Indonesia: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- Table 38 South Korea: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- Table 39 South Korea: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- Table 40 Middle East & Africa: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- Table 41 Middle East & Africa: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- Table 42 Saudi Arabia: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- Table 43 Saudi Arabia: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- Table 44 UAE: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- Table 45 UAE: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- Table 46 Israel: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- Table 47 Israel: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- Table 48 South Africa: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- Table 49 South Africa: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- Table 50 Latin America: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- Table 51 Latin America: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- Table 52 Mexico: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- Table 53 Mexico: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- Table 54 Brazil: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- Table 55 Brazil: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
- Table 56 Argentina: Angiogenesis Inhibitors and Stimulators Market, by Application, 2019-2032 (USD Billion)
- Table 57 Argentina: Angiogenesis Inhibitors and Stimulators Market, by Product, 2019-2032 (USD Billion)
List of Figures
Figure 1 Global Angiogenesis Inhibitors and Stimulators Market, 2019-2032 (USD Billion)
Figure 2 Integrated Ecosystem
Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
Figure 4 Market by Geography
Figure 5 Porter's Five Forces
Figure 6 Market by Application
Figure 7 Global Angiogenesis Inhibitors and Stimulators Market, by Application, 2021 & 2030 (USD Billion)
Figure 8 Market by Product
Figure 9 Global Angiogenesis Inhibitors and Stimulators Market, by Product, 2021 & 2030 (USD Billion)
Figure 10 Angiogenesis Inhibitors and Stimulators Market Assessment, By Geography, 2019-2032 (USD Billion)
Figure 11 Strategic Analysis - Angiogenesis Inhibitors and Stimulators Market
